Indication
Staphylococcus nosocomial pneumonia
Staphylococcus nosocomial pneumonia is an acute lower respiratory tract infection caused by *Staphylococcus* species—predominantly methicillin-susceptible or methicillin-resistant *Staphylococcus aureus*—that develops 48 hours or more following hospital admission. Read more about Staphylococcus nosocomial pneumonia
84 drugs 56 manufacturers
Drugs that treat it
Common Staphylococcus nosocomial pneumonia therapies.
ZOSYN IN DEXTROSE (ISO-OSM) (piperacillin and tazobactam in dextrose, iso-osmotic)
ZOSYN (piperacillin and tazobactam in dextrose, iso-osmotic)
LINEZOLID
LINEZOLID
LINEZOLID
LINEZOLID-D5W (linezolid in dextrose 5 % in water)
PIPERACILLIN-TAZOBACTAM (piperacillin sodium/tazobactam sodium)
PIPERACILLIN-TAZOBACTAM (piperacillin sodium/tazobactam sodium)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonStaphylococcus nosocomial pneumonia is an acute lower respiratory tract infection caused by *Staphylococcus* species—predominantly methicillin-susceptible or methicillin-resistant *Staphylococcus aureus*—that develops 48 hours or more following hospital admission.
This condition primarily affects hospitalized individuals, particularly critically ill, mechanically ventilated, or postoperative patients, as well as those with impaired airway reflexes.
Pathophysiologically, it typically arises from microaspiration of colonized oropharyngeal secretions into the pulmonary parenchyma or via hematogenous seeding from an intravascular source.
Clinically, it is characterized by new or progressive pulmonary infiltrates on chest imaging accompanied by fever, purulent sputum production, leukocytosis, and worsening respiratory failure, often carrying high morbidity due to necrotizing tissue destruction and lung cavitation.
- nih.gov
Staphylococcus nosocomial pneumonia is an acute lower respiratory tract infection caused by *Staphylococcus* species—predominantly methicillin-susceptible or methicillin-resistant *Staphylococcus aureus*—that develops 48 hours or more following hospital admission Clinically, it is characterized by new or progressive pulmonary infiltrates on chest imaging accompanied by fever, purulent sputum production, leukocytosis, and worsening respiratory failure, often carrying high morbidity due to necroti...
- nih.gov
Staphylococcus nosocomial pneumonia is an acute lower respiratory tract infection caused by *Staphylococcus* species—predominantly methicillin-susceptible or methicillin-resistant *Staphylococcus aureus*—that develops 48 hours or more following hospital admission This condition primarily affects hospitalized individuals, particularly critically ill, mechanically ventilated, or postoperative patients, as well as those with impaired airway reflexes
- nih.gov
This condition primarily affects hospitalized individuals, particularly critically ill, mechanically ventilated, or postoperative patients, as well as those with impaired airway reflexes
- merckmanuals.com
This condition primarily affects hospitalized individuals, particularly critically ill, mechanically ventilated, or postoperative patients, as well as those with impaired airway reflexes
- nih.gov
Pathophysiologically, it typically arises from microaspiration of colonized oropharyngeal secretions into the pulmonary parenchyma or via hematogenous seeding from an intravascular source
- cdc.gov
Pathophysiologically, it typically arises from microaspiration of colonized oropharyngeal secretions into the pulmonary parenchyma or via hematogenous seeding from an intravascular source
- nih.gov
Clinically, it is characterized by new or progressive pulmonary infiltrates on chest imaging accompanied by fever, purulent sputum production, leukocytosis, and worsening respiratory failure, often carrying high morbidity due to necrotizing tissue destruction and lung cavitation
Personalize your experience
Follow Staphylococcus nosocomial pneumonia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.